Related Experiment Videos
Meningeal myeloma
American Journal of Clinical Pathology
|October 1, 1982
Summary
Leptomeningeal myeloma, a rare complication of multiple myeloma, can present with varied neurological symptoms. Diagnosis relies on identifying atypical plasma cells and monoclonal immunoglobulin in cerebrospinal fluid (CSF).
Area of Science:
- Neurology
- Oncology
- Hematology
Background:
- Multiple myeloma is a plasma cell malignancy.
- Leptomeningeal myeloma involves cancer spread to the brain and spinal cord linings.
- This condition is rare but can significantly impact patient prognosis.
Observation:
- Patients may exhibit no neurological symptoms or mimic carcinomatous/lymphomatous meningitis.
- A case of leptomeningeal myeloma is presented.
- A review of previously reported cases is included.
Findings:
- Atypical plasma cells in cerebrospinal fluid (CSF) are a key diagnostic marker.
- Monoclonal immunoglobulin detected in CSF is crucial for diagnosis.
- These findings aid in identifying leptomeningeal involvement.
Implications:
- Early diagnosis of leptomeningeal myeloma is vital for timely intervention.
- Understanding diagnostic markers improves patient management.
- Further research into this rare complication is warranted.